{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:47:52Z","timestamp":1792799272472,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760495"],"award-info":[{"award-number":["81760495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Research Program of Xuzhou Health Commission","award":["KC21060"],"award-info":[{"award-number":["KC21060"]}]},{"name":"Basic Research Program of Xuzhou Health Commission","award":["KC21049"],"award-info":[{"award-number":["KC21049"]}]},{"name":"Development Foundation of Affiliated Hospital of Xuzhou Medical University","award":["XYFY2020001"],"award-info":[{"award-number":["XYFY2020001"]}]},{"name":"Development Foundation of Affiliated Hospital of Xuzhou Medical University","award":["XYFY2020002"],"award-info":[{"award-number":["XYFY2020002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Melanoma is the most lethal skin cancer characterized by its high metastatic potential. It is urgent to find novel therapy strategies to overcome this feature. Metformin has been confirmed to suppress invasion and migration of various types of cancer. However, additional mechanisms underlying the antimetastatic effect of metformin on melanoma require further investigation. Here, we performed microarray analysis and uncovered an altered mRNA and miRNA expression profile between melanoma and nevus. Luciferase reporter assay confirmed that miR-5100 targets SPINK5 to activate STAT3 phosphorylation. Migration and wound healing assays showed that the miR-5100\/SPINK5\/STAT3 axis promotes melanoma cell metastasis; the mechanism was proven by initiation of epithelial\u2013mesenchymal transition. Co-immunoprecipitation (Co-IP) further confirmed an indirect interaction between SPINK5 and STAT3. Furthermore, metformin dramatically inhibited miR-5100\/SPINK5\/STAT3 pathway, and decreased B16-F10 cell metastasis to lung in C57 mouse module. Intriguingly, pretreatment of metformin before melanoma cell injection improved this effect further. These findings exposed the underlying mechanisms of action of metformin and update the use of this drug to prevent metastasis in melanoma.<\/jats:p>","DOI":"10.1186\/s11658-022-00353-5","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T11:03:57Z","timestamp":1655291037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Metformin inhibits melanoma cell metastasis by suppressing the miR-5100\/SPINK5\/STAT3 axis"],"prefix":"10.1186","volume":"27","author":[{"given":"Dong","family":"Suwei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yanbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Jianqiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhuohui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Jianping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yunqing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5926-7832","authenticated-orcid":false,"given":"Li","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017. https:\/\/doi.org\/10.3322\/caac.21387.","journal-title":"CA Cancer J Clin"},{"key":"353_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0732-8","author":"F Dimitriou","year":"2018","unstructured":"Dimitriou F, Krattinger R, Ramelyte E, Barysch MJ, Micaletto S, Dummer R, et\u00a0al. The world of melanoma: epidemiologic, genetic, and anatomic differences of melanoma across the globe. Curr Oncol Rep. 2018. https:\/\/doi.org\/10.1007\/s11912-018-0732-8.","journal-title":"Curr Oncol Rep."},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2407-11-85","volume":"11","author":"Z Chi","year":"2011","unstructured":"Chi Z, Li S, Sheng X, Si L, Cui C, Han M, et\u00a0al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11:85. https:\/\/doi.org\/10.1186\/1471-2407-11-85.","journal-title":"BMC Cancer"},{"issue":"2","key":"353_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/j.seminoncol.2017.06.007","volume":"44","author":"V Prasad","year":"2017","unstructured":"Prasad V, Kaestner V. Nivolumab and pembrolizumab: monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable. Semin Oncol. 2017;44(2):132\u20135. https:\/\/doi.org\/10.1053\/j.seminoncol.2017.06.007.","journal-title":"Semin Oncol"},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.semcancer.2020.01.001","volume":"65","author":"K Olino","year":"2020","unstructured":"Olino K, Park T, Ahuja N. Exposing hidden targets: combining epigenetic and immunotherapy to overcome cancer resistance. Semin Cancer Biol. 2020;65:114\u201322. https:\/\/doi.org\/10.1016\/j.semcancer.2020.01.001.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"353_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.canlet.2016.03.050","volume":"376","author":"D Xiao","year":"2016","unstructured":"Xiao D, Barry S, Kmetz D, Egger M, Pan J, Rai SN, et\u00a0al. Melanoma cell-derived exosomes promote epithelial\u2013mesenchymal transition in primary melanocytes through paracrine\/autocrine signaling in the tumor microenvironment. Cancer Lett. 2016;376(2):318\u201327. https:\/\/doi.org\/10.1016\/j.canlet.2016.03.050.","journal-title":"Cancer Lett"},{"issue":"14","key":"353_CR7","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1091\/mbc.E11-04-0306","volume":"22","author":"MK Wendt","year":"2011","unstructured":"Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell. 2011;22(14):2423\u201335. https:\/\/doi.org\/10.1091\/mbc.E11-04-0306.","journal-title":"Mol Biol Cell"},{"key":"353_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005825","author":"A Hata","year":"2015","unstructured":"Hata A, Lieberman J. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal. 2015. https:\/\/doi.org\/10.1126\/scisignal.2005825.","journal-title":"Sci Signal."},{"issue":"6","key":"353_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.21873\/cgp.20221","volume":"17","author":"UH Weidle","year":"2020","unstructured":"Weidle UH, Ausl\u00c4nder S, Brinkmann U. Micro RNAs promoting growth and metastasis in preclinical in vivo models of subcutaneous melanoma. Cancer Genomics Proteomics. 2020;17(6):651\u201367. https:\/\/doi.org\/10.21873\/cgp.20221.","journal-title":"Cancer Genomics Proteomics"},{"issue":"3","key":"353_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1515\/cmble-2015-0025","volume":"20","author":"MR Fomeshi","year":"2015","unstructured":"Fomeshi MR, Ebrahimi M, Mowla SJ, Khosravani P, Firouzi J, Khayatzadeh H. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells. Cell Mol Biol Lett. 2015;20(3):448\u201365. https:\/\/doi.org\/10.1515\/cmble-2015-0025.","journal-title":"Cell Mol Biol Lett"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s11658-020-00240-x","volume":"25","author":"M Chen","year":"2020","unstructured":"Chen M, Chen C, Luo H, Ren J, Dai Q, Hu W, et\u00a0al. MicroRNA-296\u20135p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-\u03b2-induced epithelial\u2013mesenchymal transition. Cell Mol Biol Lett. 2020;25:49. https:\/\/doi.org\/10.1186\/s11658-020-00240-x.","journal-title":"Cell Mol Biol Lett."},{"issue":"5","key":"353_CR12","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/cam4.2078","volume":"8","author":"Q Wang","year":"2019","unstructured":"Wang Q, Lv Q, Bian H, Yang L, Guo KL, Ye SS, et\u00a0al. A novel tumor suppressor SPINK5 targets Wnt\/\u03b2-catenin signaling pathway in esophageal cancer. Cancer Med. 2019;8(5):2360\u201371. https:\/\/doi.org\/10.1002\/cam4.2078.","journal-title":"Cancer Med"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.2147\/cmar.S236266","volume":"12","author":"Z Lv","year":"2020","unstructured":"Lv Z, Wu K, Qin X, Yuan J, Yan M, Zhang J, et\u00a0al. A novel tumor suppressor SPINK5 serves as an independent prognostic predictor for patients with head and neck squamous cell carcinoma. Cancer Manag Res. 2020;12:4855\u201369. https:\/\/doi.org\/10.2147\/cmar.S236266.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"353_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.0022-202x.2001.01663.x","volume":"118","author":"N Komatsu","year":"2002","unstructured":"Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K, et\u00a0al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol. 2002;118(3):436\u201343. https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01663.x.","journal-title":"J Invest Dermatol"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11658-018-0078-0","volume":"23","author":"M Galoczova","year":"2018","unstructured":"Galoczova M, Coates P, Vojtesek B. STAT3, stem cells, cancer stem cells and p63. Cell Mol Biol Lett. 2018;23:12. https:\/\/doi.org\/10.1186\/s11658-018-0078-0.","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"353_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","volume":"40","author":"WH Lin","year":"2021","unstructured":"Lin WH, Chang YW, Hong MX, Hsu TC, Lee KC, Lin C, et\u00a0al. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT\u2013MET switch and cancer metastasis. Oncogene. 2021;40(4):791\u2013805. https:\/\/doi.org\/10.1038\/s41388-020-01566-8.","journal-title":"Oncogene"},{"issue":"17","key":"353_CR17","doi-asserted-by":"publisher","first-page":"11988","DOI":"10.1074\/jbc.M112.428516","volume":"288","author":"MS Waitkus","year":"2013","unstructured":"Waitkus MS, Chandrasekharan UM, Willard B, Haque SJ, DiCorleto PE. STAT3-mediated coincidence detection regulates noncanonical immediate early gene induction. J Biol Chem. 2013;288(17):11988\u20132003. https:\/\/doi.org\/10.1074\/jbc.M112.428516.","journal-title":"J Biol Chem"},{"issue":"4","key":"353_CR18","doi-asserted-by":"publisher","first-page":"H1265","DOI":"10.1152\/ajpheart.00092.2010","volume":"299","author":"CC Smith","year":"2010","unstructured":"Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S, et\u00a0al. Leptin-induced cardioprotection involves JAK\/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol. 2010;299(4):H1265\u201370. https:\/\/doi.org\/10.1152\/ajpheart.00092.2010.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/ph14020122","volume":"14","author":"J Drzewoski","year":"2021","unstructured":"Drzewoski J, Hanefeld M. The current and potential therapeutic use of metformin\u2014the good old drug. Pharmaceuticals (Basel, Switzerland). 2021;14:2. https:\/\/doi.org\/10.3390\/ph14020122.","journal-title":"Pharmaceuticals (Basel, Switzerland)."},{"issue":"9","key":"353_CR20","first-page":"4885","volume":"12","author":"YC Chen","year":"2020","unstructured":"Chen YC, Li H, Wang J. Mechanisms of metformin inhibiting cancer invasion and migration. Am J Transl Res. 2020;12(9):4885\u2013901.","journal-title":"Am J Transl Res"},{"key":"353_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-015-0203-8","volume":"8","author":"D Suwei","year":"2015","unstructured":"Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, et\u00a0al. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. J Hematol Oncol. 2015;8:120. https:\/\/doi.org\/10.1186\/s13045-015-0203-8.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"353_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods (San Diego, Calif). 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods (San Diego, Calif)"},{"key":"353_CR23","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.2147\/ott.S219977","volume":"12","author":"S Dong","year":"2019","unstructured":"Dong S, Xiao Y, Ma X, He W, Kang J, Peng Z, et\u00a0al. miR-193b increases the chemosensitivity of osteosarcoma cells by promoting FEN1-mediated autophagy. Onco Targets Ther. 2019;12:10089\u201398. https:\/\/doi.org\/10.2147\/ott.S219977.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"353_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A, et\u00a0al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell. 2013;24(4):466\u201380. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.018.","journal-title":"Cancer Cell"},{"key":"353_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9010217","volume":"9","author":"W Jin","year":"2020","unstructured":"Jin W. Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial\u2013mesenchymal transition. Cells. 2020;9:1. https:\/\/doi.org\/10.3390\/cells9010217.","journal-title":"Cells"},{"issue":"8","key":"353_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/08941939.2019.1701754","volume":"34","author":"Z Wei","year":"2021","unstructured":"Wei Z, Lyu B, Hou D, Liu X. Mir-5100 mediates proliferation, migration and invasion of oral squamous cell carcinoma cells via targeting SCAI. J Invest Surg. 2021;34(8):834\u201341. https:\/\/doi.org\/10.1080\/08941939.2019.1701754.","journal-title":"J Invest Surg"},{"issue":"10","key":"353_CR27","first-page":"4694","volume":"9","author":"CY Li","year":"2017","unstructured":"Li CY, Wang YH, Lin ZY, Yang LW, Gao SL, Liu T, et\u00a0al. MiR-5100 targets TOB2 to drive epithelial\u2013mesenchymal transition associated with activating smad2\/3 in lung epithelial cells. Am J Transl Res. 2017;9(10):4694\u2013706.","journal-title":"Am J Transl Res"},{"issue":"3","key":"353_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jdermsci.2010.12.004","volume":"61","author":"D Roedl","year":"2011","unstructured":"Roedl D, Oji V, Buters JT, Behrendt H, Braun-Falco M. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients. J Dermatol Sci. 2011;61(3):194\u20138. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.12.004.","journal-title":"J Dermatol Sci"},{"key":"353_CR29","doi-asserted-by":"publisher","first-page":"6650781","DOI":"10.1155\/2021\/6650781","volume":"2021","author":"RG Li","year":"2021","unstructured":"Li RG, Deng H, Liu XH, Chen ZY, Wan SS, Wang L. Histone methyltransferase G9a promotes the development of renal cancer through epigenetic silencing of tumor suppressor gene SPINK5. Oxid Med Cell Longev. 2021;2021:6650781. https:\/\/doi.org\/10.1155\/2021\/6650781.","journal-title":"Oxid Med Cell Longev"},{"key":"353_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100970","author":"MG Alves","year":"2021","unstructured":"Alves MG, Kodama MH, da Silva EZM, Gomes BBM, da Silva RAA, Vieira GV, et\u00a0al. Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma. Transl Oncol. 2021. https:\/\/doi.org\/10.1016\/j.tranon.2020.100970.","journal-title":"Transl Oncol."},{"key":"353_CR31","doi-asserted-by":"publisher","unstructured":"van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, et\u00a0al. Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol 2012. https:\/\/doi.org\/10.1200\/jco.2011.40.4509.","DOI":"10.1200\/jco.2011.40.4509"},{"issue":"1","key":"353_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/ijms.48552","volume":"18","author":"W Liu","year":"2021","unstructured":"Liu W, Huang G, Yang Y, Gao R, Zhang S, Kou B. Oridonin inhibits epithelial\u2013mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT\/STAT3 signaling pathway. Int J Med Sci. 2021;18(1):81\u20137. https:\/\/doi.org\/10.7150\/ijms.48552.","journal-title":"Int J Med Sci"},{"issue":"11","key":"353_CR33","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1074\/jbc.271.11.5961","volume":"271","author":"A Kaptein","year":"1996","unstructured":"Kaptein A, Paillard V, Saunders M. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem. 1996;271(11):5961\u20134. https:\/\/doi.org\/10.1074\/jbc.271.11.5961.","journal-title":"J Biol Chem"},{"issue":"6","key":"353_CR34","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1172\/jci82887","volume":"126","author":"T Yasuda","year":"2016","unstructured":"Yasuda T, Fukada T, Nishida K, Nakayama M, Matsuda M, Miura I, et\u00a0al. Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis. J Clin Investig. 2016;126(6):2064\u201376. https:\/\/doi.org\/10.1172\/jci82887.","journal-title":"J Clin Investig"},{"issue":"8","key":"353_CR35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1373\/clinchem.2007.088104","volume":"53","author":"JL Shaw","year":"2007","unstructured":"Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem. 2007;53(8):1423\u201332. https:\/\/doi.org\/10.1373\/clinchem.2007.088104.","journal-title":"Clin Chem"},{"issue":"9","key":"353_CR36","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1091\/mbc.e07-02-0124","volume":"18","author":"C Deraison","year":"2007","unstructured":"Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, Jayakumar A, et\u00a0al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell. 2007;18(9):3607\u201319. https:\/\/doi.org\/10.1091\/mbc.e07-02-0124.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"353_CR37","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.21873\/anticanres.14896","volume":"41","author":"Y Lee","year":"2021","unstructured":"Lee Y, Park D. Effect of metformin in combination with trametinib and paclitaxel on cell survival and metastasis in melanoma cells. Anticancer Res. 2021;41(3):1387\u201399. https:\/\/doi.org\/10.21873\/anticanres.14896.","journal-title":"Anticancer Res"},{"issue":"7503","key":"353_CR38","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ (Clin Res Ed). 2005;330(7503):1304\u20135. https:\/\/doi.org\/10.1136\/bmj.38415.708634.F7.","journal-title":"BMJ (Clin Res Ed)"},{"key":"353_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.09.012","author":"DM Baur","year":"2011","unstructured":"Baur DM, Klotsche J, Hamnvik OP, Sievers C, Pieper L, Wittchen HU, et\u00a0al. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism. 2011. https:\/\/doi.org\/10.1016\/j.metabol.2010.09.012.","journal-title":"Metabolism"},{"key":"353_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-04043-8","author":"A Farahi","year":"2021","unstructured":"Farahi A, Abedini MR, Javdani H, Arzi L, Chamani E, Farhoudi R, et\u00a0al. Crocin and metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies. Mol Cell Biochem. 2021. https:\/\/doi.org\/10.1007\/s11010-020-04043-8.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"353_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1158\/1541-7786.Mcr-20-0115","volume":"19","author":"E Kawakita","year":"2021","unstructured":"Kawakita E, Yang F, Kumagai A, Takagaki Y, Kitada M, Yoshitomi Y, et\u00a0al. Metformin mitigates DPP-4 inhibitor-induced breast cancer metastasis via suppression of mTOR signaling. Mol Cancer Res. 2021;19(1):61\u201373. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-20-0115.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"353_CR42","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/1535-7163.Mct-12-1226-t","volume":"12","author":"M Cerezo","year":"2013","unstructured":"Cerezo M, Tichet M, Abbe P, Ohanna M, Lehraiki A, Rouaud F, et\u00a0al. Metformin blocks melanoma invasion and metastasis development in AMPK\/p53-dependent manner. Mol Cancer Ther. 2013;12(8):1605\u201315. https:\/\/doi.org\/10.1158\/1535-7163.Mct-12-1226-t.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"353_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tranon.2019.02.001","volume":"12","author":"K Okubo","year":"2019","unstructured":"Okubo K, Isono M, Asano T, Sato A. Metformin augments panobinostat\u2019s anti-bladder cancer activity by activating AMP-activated protein kinase. Transl Oncol. 2019;12(4):669\u201382. https:\/\/doi.org\/10.1016\/j.tranon.2019.02.001.","journal-title":"Transl Oncol"},{"key":"353_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cancers11020209","volume":"11","author":"HW Tseng","year":"2019","unstructured":"Tseng HW, Li SC, Tsai KW. Metformin treatment suppresses melanoma cell growth and motility through modulation of microRNA expression. Cancers. 2019;11:2. https:\/\/doi.org\/10.3390\/cancers11020209.","journal-title":"Cancers"},{"issue":"1","key":"353_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jtho.2020.08.021","volume":"16","author":"J Kang","year":"2021","unstructured":"Kang J, Jeong SM, Shin DW, Cho M, Cho JH, Kim J. The associations of aspirin, statins, and metformin with lung cancer risk and related mortality: a time-dependent analysis of population-based nationally representative data. J Thorac Oncol. 2021;16(1):76\u201388. https:\/\/doi.org\/10.1016\/j.jtho.2020.08.021.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"353_CR46","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jdiacomp.2016.04.003","volume":"30","author":"L Jacob","year":"2016","unstructured":"Jacob L, Kostev K, Rathmann W, Kalder M. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes. J Diabetes Complications. 2016;30(6):1056\u20139. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.04.003.","journal-title":"J Diabetes Complications"},{"issue":"5","key":"353_CR47","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/cncr.26439","volume":"118","author":"S Bayraktar","year":"2012","unstructured":"Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, et\u00a0al. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer. 2012;118(5):1202\u201311. https:\/\/doi.org\/10.1002\/cncr.26439.","journal-title":"Cancer"},{"issue":"4","key":"353_CR48","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10557-020-07040-7","volume":"35","author":"M Witkowski","year":"2021","unstructured":"Witkowski M, Friebel J, Tabaraie T, Grabitz S, D\u00f6rner A, Taghipour L, et\u00a0al. Metformin is associated with reduced tissue factor procoagulant activity in patients with poorly controlled diabetes. Cardiovasc Drugs Ther. 2021;35(4):809\u201313. https:\/\/doi.org\/10.1007\/s10557-020-07040-7.","journal-title":"Cardiovasc Drugs Ther"},{"key":"353_CR49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13046-019-1211-2","volume":"38","author":"JC Wang","year":"2019","unstructured":"Wang JC, Li GY, Wang B, Han SX, Sun X, Jiang YN, et\u00a0al. Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation. J Exp Clin Cancer Res. 2019;38:235. https:\/\/doi.org\/10.1186\/s13046-019-1211-2.","journal-title":"J Exp Clin Cancer Res"},{"key":"353_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/jitc-2021-002773","volume":"9","author":"R Veeramachaneni","year":"2021","unstructured":"Veeramachaneni R, Yu W, Newton JM, Kemnade JO, Skinner HD, Sikora AG, et\u00a0al. Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects. J Immunother Cancer. 2021;9:7. https:\/\/doi.org\/10.1136\/jitc-2021-002773.","journal-title":"J Immunother Cancer."},{"issue":"5","key":"353_CR51","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/cac2.12147","volume":"41","author":"PC Chou","year":"2021","unstructured":"Chou PC, Choi HH, Huang Y, Fuentes-Mattei E, Velazquez-Torres G, Zhang F, et\u00a0al. Impact of diabetes on promoting the growth of breast cancer. Cancer Commun (London, England). 2021;41(5):414\u201331. https:\/\/doi.org\/10.1002\/cac2.12147.","journal-title":"Cancer Commun (London, England)"},{"issue":"18","key":"353_CR52","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1158\/1078-0432.Ccr-20-0113","volume":"26","author":"S Wang","year":"2020","unstructured":"Wang S, Lin Y, Xiong X, Wang L, Guo Y, Chen Y, et\u00a0al. Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: results of a phase II clinical trial. Clini Cancer Res. 2020;26(18):4921\u201332. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-0113.","journal-title":"Clini Cancer Res"},{"key":"353_CR53","doi-asserted-by":"publisher","first-page":"175628482092727","DOI":"10.1177\/1756284820927271","volume":"13","author":"S Pusceddu","year":"2020","unstructured":"Pusceddu S, Vernieri C, Prinzi N, Torchio M, Coppa J, Antista M, et\u00a0al. The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence. Ther Adv Gastroenterol. 2020;13:1756284820927271. https:\/\/doi.org\/10.1177\/1756284820927271.","journal-title":"Ther Adv Gastroenterol"},{"issue":"16","key":"353_CR54","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.7150\/thno.54961","volume":"11","author":"T Deng","year":"2021","unstructured":"Deng T, Shen P, Li A, Zhang Z, Yang H, Deng X, et\u00a0al. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics. 2021;11(16):8112\u201328. https:\/\/doi.org\/10.7150\/thno.54961.","journal-title":"Theranostics"},{"issue":"6","key":"353_CR55","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1021\/acs.nanolett.9b00495","volume":"19","author":"T Jiang","year":"2019","unstructured":"Jiang T, Chen L, Huang Y, Wang J, Xu M, Zhou S, et\u00a0al. Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression. Nano Lett. 2019;19(6):3548\u201362. https:\/\/doi.org\/10.1021\/acs.nanolett.9b00495.","journal-title":"Nano Lett"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00353-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-022-00353-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00353-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T11:04:47Z","timestamp":1655291087000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-022-00353-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1186\/s11658-022-00353-5","relation":{},"ISSN":["1425-8153","1689-1392"],"issn-type":[{"value":"1425-8153","type":"print"},{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Medical Ethics Committee of the Third Affiliated Hospital of Kunming Medical University. The procedures for the collection and use of tissues were performed in accordance with the guidelines of the Helsinki Declaration of 2013 (no. 2016-16, 2 March 2017, for both patients and animals).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}